242 related articles for article (PubMed ID: 7943174)
1. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
Shih IM; Elder DE; Hsu MY; Herlyn M
Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174
[TBL] [Abstract][Full Text] [Related]
2. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.
Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M
Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes express the CD146 (Muc18/S-endo) antigen in tissue culture and during inflammatory skin diseases.
Weninger W; Rendl M; Mildner M; Mayer C; Ban J; Geusau A; Bayer G; Tanew A; Majdic O; Tschachler E
J Invest Dermatol; 2000 Aug; 115(2):219-24. PubMed ID: 10951239
[TBL] [Abstract][Full Text] [Related]
5. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
6. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma.
Shih LM; Hsu MY; Palazzo JP; Herlyn M
Am J Pathol; 1997 Sep; 151(3):745-51. PubMed ID: 9284823
[TBL] [Abstract][Full Text] [Related]
7. Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM).
Schön M; Kähne T; Gollnick H; Schön MP
J Invest Dermatol; 2005 Aug; 125(2):353-63. PubMed ID: 16098047
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen.
Kraus A; Masat L; Johnson JP
Melanoma Res; 1997 Aug; 7 Suppl 2():S75-81. PubMed ID: 9578420
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.
Hsu MY; Meier FE; Nesbit M; Hsu JY; Van Belle P; Elder DE; Herlyn M
Am J Pathol; 2000 May; 156(5):1515-25. PubMed ID: 10793063
[TBL] [Abstract][Full Text] [Related]
10. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma.
Meier F; Caroli U; Satyamoorthy K; Schittek B; Bauer J; Berking C; Möller H; Maczey E; Rassner G; Herlyn M; Garbe C
Exp Dermatol; 2003 Jun; 12(3):296-306. PubMed ID: 12823444
[TBL] [Abstract][Full Text] [Related]
12. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
Rummel MM; Sers C; Johnson JP
Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
[TBL] [Abstract][Full Text] [Related]
14. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
15. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.
Sers C; Riethmüller G; Johnson JP
Cancer Res; 1994 Nov; 54(21):5689-94. PubMed ID: 7923217
[TBL] [Abstract][Full Text] [Related]
16. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.
Lehmann JM; Riethmüller G; Johnson JP
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381
[TBL] [Abstract][Full Text] [Related]
17. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
Shih IM; Nesbit M; Herlyn M; Kurman RJ
Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
[TBL] [Abstract][Full Text] [Related]
18. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules.
Grimm T; Johnson JP
Cancer Res; 1995 Aug; 55(15):3254-7. PubMed ID: 7614458
[TBL] [Abstract][Full Text] [Related]
20. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
